Researchers open the way to new treatments for chronic pain, cancer

Posted by on April 13, 2016 12:41 pm
Categories: health

A discovery of the full-length structure of a protein named Transient Receptor Potential Vanilloid subtype 2 (TRPV2) has been described in a new paper. Taken in addition to their study of its molecular mechanism last year, researchers have revealed TRPV2 as new target for pharmaceutical research treating chronic pain and cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *